Trials & Tribulations Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage July 16, 2021Vol.47 No.28By Henry S. Friedman and John D. Lee
Trials & Tribulations Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA June 18, 2021Vol.47 No.24By Howard S. Hochster and Michael P. Kane
FreeTrials & Tribulations Precision oncology must evolve to address health disparities June 04, 2021Vol.47 No.22By Brandon Mahal and Jeffrey Venstrom
Trials & Tribulations It’s time to rethink clinical trials in a post-pandemic world May 14, 2021Vol.47 No.19By Dana Dornsife
Trials & Tribulations Best practices in preventing heartbreak:A look at a SWOG cancer control trial April 16, 2021Vol.47 No.15By Justin Floyd and Monika Leja
Trials & Tribulations Setting a research agenda on cannabis and cannabinoids: Updates from the NCI symposium April 09, 2021Vol.47 No.14By Dylan M. Zylla
FreeTrials & Tribulations City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation February 19, 2021Vol.47 No.07By Harlan Levine and Joseph Alvarnas
FreeTrials & Tribulations The Delaware experience:Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19 February 05, 2021Vol.47 No.05By Nicholas J. Petrelli, Nora Katurakes, Rose Mili and Charlene Marinelli
FreeTrials & Tribulations Tackling racial disparities through novel approaches to engage communities in research January 29, 2021Vol.47 No.04By Hayley S. Thompson
Trials & Tribulations An oncologist’s perspective on measuring success in the clinic January 15, 2021Vol.47 No.02By Steven R. Grossman
